Genetic testing in familial and young-onset Alzheimer's disease: Mutation spectrum in a Serbian cohort

Valerija Dobricic, Elka Stefanova, Milena Jankovic, Nicole Gurunlian, Ivana Novakovic, John Hardy, Vladimir Kostic, Rita Guerreiro*

*Korrespondierende/r Autor/-in für diese Arbeit
    18 Zitate (Scopus)

    Abstract

    Alzheimer's disease (AD) is the most common form of dementia. To date, more than 200 mutations in three genes have been identified as cause of early-onset autosomal dominant inherited AD. The aim of this study was to characterize the mutation spectrum and describe genotype-phenotype correlations in Serbian patients with positive family history of AD or/and early-onset AD. We performed a genetic screening for mutations in the coding regions of Presenilins 1 and 2 (PSEN1 and PSEN2), as well as exons 16 and 17 of the Amyloid Precursor Protein gene (APP) in a total of 47 patients from Serbia with a clinical diagnosis of familial and/or early-onset AD (mean age at onset of 60.3 years; range 32-77). We found one novel mutation in PSEN1, one novel variant in PSEN2, and three previously described variants, one in each of the analyzed genes. Interestingly, we identified one patient harboring two heterozygous mutations: one in APP (p.L723P) and one in PSEN1 (p.R108Q).

    OriginalspracheEnglisch
    ZeitschriftNeurobiology of Aging
    Jahrgang33
    Ausgabenummer7
    Seiten (von - bis)1481.e7-1481.e12
    ISSN0197-4580
    DOIs
    PublikationsstatusVeröffentlicht - 07.2012

    Fingerprint

    Untersuchen Sie die Forschungsthemen von „Genetic testing in familial and young-onset Alzheimer's disease: Mutation spectrum in a Serbian cohort“. Zusammen bilden sie einen einzigartigen Fingerprint.

    Zitieren